-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723.P1.33 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, Biological, Follicular Lymphoma, Leukemia, multiple myeloma, survivorship, Bleeding and Clotting, bone marrow, CLL, CML, Diseases, Lymphoma (any), Marginal Zone Lymphoma, Non-Biological, Bone Marrow Failure, CMML, Combinations, Elderly, Hodgkin Lymphoma, Mantle Cell Lymphoma, thalassemia, Therapies, Adverse Events, chemotherapy, CNS Lymphoma, MDS, Non-Hodgkin Lymphoma, Pediatric, B-Cell Lymphoma, DLBCL, Hemoglobinopathies, MPN, T-Cell Lymphoma, Technology and Procedures, Young Adult, Infectious Diseases, Plasma Cell Disorders, infusion, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement , Thrombotic Disorders, flow cytometry, transplantation, TTP, stem cells
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Xueying Wu1*, Hui Wang, MD2*, Aixian Wang3*, Xingyu Cao4*, Meiwei Gong3*, Junyi Zhen3*, Man Chen3*, Qing Du3* and Peihua Lu, MD5

1Pathology & Laboratory Medicine Division, Hebei Yanda Ludaopei Hospital, Langfang, China
2Pathology & Laboratory Medicine Division, Hebei Yanda Lu Daopei Hospital, Beijing, Beijing, China
3Pathology & Laboratory Medicine Division, Hebei Yanda Ludaopei hospital, Langfang, China
4Bone Marrow Transplant Department, Hebei Yanda Lu Daopei Hospital, Langfang, China
5Hebei Yanda Lu Daopei Hospital, Langfang, China

Ang Li, MD, MS1, Hanqing Shang2*, Rohit Gupta2, Chris Davis, M.S.3*, Stephanie J. Lee, MD, MPH3 and Sangeeta R Hingorani, MD, MPH4,5*

1Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX
2Baylor College of Medicine, Houston, TX
3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4Division of Nephrology, Seattle Children's Hospital, Seattle, WA
5Department of Pediatrics, University of Washington School of Medicine, Seattle, WA

Wanxia Tan1*, Yuelin He, MD1*, Xiaoqin Feng1*, Xuedong Wu, MD, PhD,1*, Chunfu Li, MD2, Jianyun Liao, MD2*, Huaying Liu, MD2*, Xuan Liu1*, Fuyu Pei1*, Qiujun Liu1*, Xiaoting Liu1* and Yuqiong Ren1*

1Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Nanfang-Chunfu Children's Institute of Hematology, Taixin Hospital of DongGuan, DongGuan, China

Igor Nicolas Novitzky-Basso, MD, PhD, MRCP, FRCPath1, Ivan Pasic, MD, PhD2*, Zeyad Al-Shaibani, MD1*, Wilson Lam, MD1*, Arjun Law, MD1*, Armin Gerbitz, MD PhD1*, Auro Viswabandya, MD, DM1*, Jeffrey H. Lipton, MD, PhD1, Rajat Kumar, MD1, Jonas Mattsson, MD1*, Fotios Michelis, MD, PhD1* and Dennis Dong Hwan Kim, MD, PhD1*

1Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
2Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Noha N. Soror, MD1*, Ashleigh Keiter, MS2*, Qiuhong Zhao, MS3*, Julianna Roddy, PharmD4*, Sam Penza, MD3, Jonathan E Brammer, MD5, Yvonne A. Efebera, MD, MPH6, Don M. Benson Jr., MD, PhD3, Sumithra Vasu, MD, MBBS7, Alice S. Mims, MD8, Bradley W Blaser, MD, PhD9, Hannah Choe, MD10, Karilyn Larkin, MD3, Nicole Grieselhuber, MD, PhD8*, Sarah A Wall, MD2, Ayman Saad, MD3, Ashley Rosko, MD3, Patrick Elder, MS3*, Maria Chaudhry, MD3, Naresh Bumma, MD3, Abdullah Khan, MBBS, MSc3, Srinivas Devarakonda, MD3, Samantha Jaglowski, MD, MPH11 and Basem M. William, MD, MRCP5

1Internal Medicine, Western Reserve Health Education, Warren, OH
2Division of Hematology, The Ohio State University, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
4Department of Pharmacy, The Ohio State University, Columbus, OH
5The Ohio State University James Comprehensive Cancer Center, Columbus, OH
6Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
7Comprehensive Cancer Center, The Ohio State University, Columbus, OH
8The Ohio State University Comprehensive Cancer Center, Columbus, OH
9The Ohio State University Comprehensive Cancer Center and Division of Hematology, Columbus, OH
10The Ohio State University Comprehensive Cancer Center, Columbus
11The Ohio State University, Columbus, OH

Farwah N. Fatima, MBBS1*, Muhammad Ashar Ali, MD2*, Anum Javaid, MD3*, Rimsha Ali3*, Aqsa Mumtaz, MBBS2*, Wajeeha Aiman, MD4*, Nayab Mirza, MD2*, Sana Khan, MBBS5*, Hamza Hashmi, MD6 and Faiz Anwer, MD7

1Lahore Medical and Dental College, Lahore, Pakistan
2King Edward Medical University, Lahore, Pakistan
3Rawalpindi Medical University, Rawalpindi, Pakistan
4Nishtar Medical University, Multan, Pakistan
5Shifa College of Medicine, Islamabad, Pakistan
6Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC
7Taussig Cancer Institute, Cleveland Clinic, Cleveland

Ke Wang1*, Songhai Zhou1*, Yuqian Sun, MD2*, Chenhua Yan3,4,5*, Yu Wang2,5,6*, Xiaojun Huang, MD7,8 and Xiaosu Zhao, PhD2,8*

1Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
2Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
3Peking University Institute of Hematology, Beijing, China
4Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
5National Clinical Research Center for Hematologic Disease, Beijing, China
6Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
7Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
8Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Sarah Morin, MD, PhD1*, Federica Giannotti, MD1*, Anne-Claire Mamez, MD2*, Stavroula Masouridi-Levrat, MD2*, Federico Simonetta, MD, PhD1* and Yves Chalandon, MD2

1Geneva University Hospitals, Geneva, Switzerland
2Département d’Oncologie, Service d’Hématologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland

Shona Philip, BSc, MD1, Adrienne Fulford, NP, MSN2*, Krista Biederman, BScPhm3*, Brandon Dorland, NP, MSN4*, Anargyros Xenocostas, MD, FRCPC5 and Uday Deotare, MBBS, MD, DM6*

1Western University, London Health Sciences Center, London, ON, Canada
2London Health Sciences Center, London, ON, CAN
3London Health Sciences Centre, London, ON, Canada
4London Health Sciences Center, London, Canada
5Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
6Division of Hematology, Department of Medicine, London Health Sciences Centre, London, ON, Canada

Mobeen Zaka Haider, MD, MBBS1*, Zarlakhta Zamani, MBBS1*, Muhammad Taqi, MBBS2*, Hafsa Shahid1*, Zahoor Ahmed, MD3*, Hasan Mahmood Mirza4*, Aneeza Irfan, MD5*, Khadija Noor Sami, MD6*, Deepak Kumar, MD7*, Fnu Kiran, MD8*, Mydah Sajid Hashmi, MD9* and Faiz Anwer, MD10

1King Edward Medical University, Lahore, Pakistan
2Mayo Hospital, Lahore, Pakistan
3Department of Internal Medicine, King Edward Medical University, Lahore, Pakistan
4Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, Boston, MA
5University of Missouri Kansas City, Kansas City
6Services Institute Of Medical Sciences, Lahore, Pakistan
7Jinnah Postgraduate Medical Center, Karachi, Pakistan
8Sindh institute of urology and transplantation, Karachi, Pakistan
9Army Medical College, Islamabad, Pakistan
10Department of Hematology & Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Moreland Hills, OH

*signifies non-member of ASH